Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

5.6K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial soluble APP/APLP2 promote heart repair through KIT-mediated angiogenesis.

Science advances·2026
Same author

Necroptosis in both tumour and stromal compartments determines responsiveness to immunogenic cell death-based immunotherapy.

Nature communications·2026
Same author

The Concise Guide to PHARMACOLOGY 2025/26: Ion channels.

British journal of pharmacology·2025
Same author

The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.

British journal of pharmacology·2025
Same author

Nuclear eNOS Interacts With and <i>S</i>-Nitrosates ADAR1 to Modulate Type I Interferon Signaling and Endothelial Function.

Circulation·2025
Same author

Orphan receptor GPR153 facilitates vascular damage responses by modulating cAMP levels, YAP/TAZ signaling, and NF-κB activation.

Nature communications·2025
Same journal

A phase 1b study of chemo-immunotherapy with pegylated liposomal doxorubicin and Pembrolizumab in estrogen receptor positive metastatic breast cancer.

Cancer research communications·2026
Same journal

DNA Methyltransferase Inhibition Prevents Platinum-Induced Ovarian Cancer Stem Cell Enrichment.

Cancer research communications·2026
Same journal

Chemotherapy Induced Neutropenia in Palestinian Patients with Solid Malignancies: Patient Characteristics, Severity Risk Factors & Management Patterns.

Cancer research communications·2026
Same journal

Phase 1 study of oncolytic virus VV1 as monotherapy or in combination with avelumab in patients with relapsed refractory solid tumors.

Cancer research communications·2026
Same journal

Tumor-Associated Platelets Suppress T-Cell Function and Promote Immune Evasion in TNBC via the P-selectin/ P-selectin glycoprotein ligand-1 Pathway.

Cancer research communications·2026
Same journal

Development of Glypican-3-Targeting Antibody-Drug Conjugates for Hepatocellular Carcinoma Therapy.

Cancer research communications·2026
See all related articles

Related Experiment Video

Updated: Aug 6, 2025

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.4K

Plexin-B1 Mutation Drives Metastasis in Prostate Cancer Mouse Models.

Boris Shorning1, Neil Trent1, David F Griffiths2

  • 1European Cancer Stem Cell Research Institute, School of Biosciences, Cardiff University, Cardiff, United Kingdom.

Cancer Research Communications
|March 20, 2023
PubMed
Summary
This summary is machine-generated.

A mutant form of Plexin-B1 (P1597L) promotes prostate cancer metastasis, while the wild-type form suppresses it. Targeting Plexin-B1 may block cancer spread.

More Related Videos

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.3K
An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis
08:11

An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis

Published on: August 14, 2016

31.2K

Related Experiment Videos

Last Updated: Aug 6, 2025

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer
07:01

Pre-clinical Orthotopic Murine Model of Human Prostate Cancer

Published on: August 29, 2016

14.4K
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.3K
An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis
08:11

An Orthotopic Mouse Model of Spontaneous Breast Cancer Metastasis

Published on: August 14, 2016

31.2K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metastasis

Background:

  • Metastatic prostate cancer is a leading cause of death with poorly understood molecular drivers.
  • Plexins, semaphorin receptors, have varied roles in cancer progression.
  • Identifying specific targets to prevent prostate cancer dissemination is crucial.

Purpose of the Study:

  • To investigate the role of Plexin-B1, particularly a mutant form (P1597L), in prostate cancer metastasis.
  • To determine if Plexin-B1 can be a therapeutic target for advanced prostate cancer.

Main Methods:

  • Utilized two transgenic mouse models of prostate cancer (PbCre and PbCre).
  • Examined the effects of prostate epithelial cell-specific expression of wild-type (WT) and mutant (P1597L) Plexin-B1.
  • Assessed tumor cell invasion and metastasis.
  • Investigated the involvement of the Rho/ROCK pathway and germline deletion of Plexin-B1.

Main Results:

  • Prostate epithelial cell-specific expression of mutant Plexin-B1 (P1597L) significantly increased metastasis.
  • Wild-type Plexin-B1 significantly decreased metastasis, indicating a switch from suppressor to promoter.
  • Mutant Plexin-B1 enhanced tumor cell invasion, while WT Plexin-B1 reduced it.
  • Rho/ROCK pathway inhibition and germline Plexin-B1 deletion suppressed metastasis.

Conclusions:

  • Plexin-B1 plays a complex role in prostate cancer metastasis, with a specific mutation converting it to a promoter.
  • Plexin-B1 signaling, especially the P1597L mutant, represents a potential therapeutic target to inhibit prostate cancer spread.